Cargando…
Randomised trial of neonatal hypoglycaemia prevention with oral dextrose gel (hPOD): study protocol
BACKGROUND: Neonatal hypoglycaemia is common, affecting up to 15 % of newborn babies and 50 % of those with risk factors (preterm, infant of a diabetic, high or low birthweight). Hypoglycaemia can cause brain damage and death, and babies born at risk have an increased risk of developmental delay in...
Autores principales: | Harding, Jane E, Hegarty, Joanne E, Crowther, Caroline A, Edlin, Richard, Gamble, Greg, Alsweiler, Jane M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4572621/ https://www.ncbi.nlm.nih.gov/pubmed/26377909 http://dx.doi.org/10.1186/s12887-015-0440-6 |
Ejemplares similares
-
Prophylactic Oral Dextrose Gel for Newborn Babies at Risk of Neonatal Hypoglycaemia: A Randomised Controlled Dose-Finding Trial (the Pre-hPOD Study)
por: Hegarty, Joanne Elizabeth, et al.
Publicado: (2016) -
Evaluation of oral dextrose gel for prevention of neonatal hypoglycemia (hPOD): A multicenter, double-blind randomized controlled trial
por: Harding, Jane E., et al.
Publicado: (2021) -
Neurocognitive Outcomes at Age 2 Years After Neonatal Hypoglycemia in a Cohort of Participants From the hPOD Randomized Trial
por: Edwards, Taygen, et al.
Publicado: (2022) -
Cost burden and net monetary benefit loss of neonatal hypoglycaemia
por: Glasgow, Matthew J., et al.
Publicado: (2021) -
Oral diazoxide versus placebo for severe or recurrent neonatal hypoglycaemia: Neonatal Glucose Care Optimisation (NeoGluCO) study – a randomised controlled trial
por: Laing, Don, et al.
Publicado: (2022)